Second Annual Predictive Preclinical Models in Oncology

The selection of appropriate animal models based on similarity to human biology carries considerable potential to ensure a higher predictability of preclinical results. Innovative ex vivo models are equally important for minimizing the odds of preclinical errors. This conference is designed to highlight the cutting edge in vitro and in vivo preclinical models that allow researchers to more effectively evaluate novel cancer therapeutics, as well as to identify predictive biomarkers in early stages of drug development. Case studies and solutions for increasing the predictability of preclinical cancer studies will be presented.